Accessibility / Report Error
(Updated: 2022/02/09)

About the journal

 

Basic informations

 

The journal Arquivos Brasileiros de Oftalmologia, the official organ of the Brazilian Council of Ophthalmology, is published bimonthly since 1938. Its objective is to register the scientific production in Ophthalmology, to foment the study, improvement and updating of the professionals of the specialty.

Its abbreviated title is Arq Bras Oftalmol, which should be used in bibliographies, footnotes and bibliographical references and strips.

 

 

Intellectual property rights

 

All journal content, except where identified, is licensed under a Creative Commons CC-BY attribution-type license.

The online journal has free and open access.

 

 

Indexing sources

 

The articles published in Arquivos Brasileiros de Oftalmologia are indexed by:

  • Thomson Reuters - ISI Wed of Knowledge
  • Periódica
  • Medline
  • LILACS - Literatura Latino-americana em Ciências da saúde
  • SCOPUS
  • EMBASE.com
  • Scielo
  • Latindex
 

 


 

 

Editorial Board

 

Chief editor

 
  • Eduardo Melani Rocha, Universidade São Paulo, Ribeirão Preto - SP - Brasil
 

 

Associate editors

 
  • André Messias, Universidade de São Paulo, Ribeirão Preto - SP- Brasil
  • Caio Vinicius Regatieri, Universidade Federal de São Paulo, São Paulo - SP - Brasil
  • Carolina P. B. Gracitelli, Universidade Federal de São Paulo, São Paulo – SP - Brasil
  • Cintia de Paiva, Baylor College of Medicine, Houston – Texas - USA
  • Dácio Carvalho Costa – Universidade Estadual do Ceará, Fortaleza – CE - Brasil
  • Jayter Silva de Paula, Universidade de São Paulo, Ribeirão Preto - SP - Brasil
  • Júlia Rossetto, Universidade Federal de São Paulo, São Paulo – SP - Brasil
  • Laurentino Biccas Neto, Universidade Federal do Espírito Santo, Vitória – ES – Brasil
  • Luísa Moreira Hopker, Universidade Positivo, Curitiba – PR -  Brasil
  • Mônica Alves, Universidade Estadual de Campinas – Campinas – SP - Brasil
  • Newton Kara Jr, Universidade de São Paulo, São Paulo - SP - Brasil
  • Ricardo Mörschbächer, Universidade Federal das Ciências da Saúde de Porto Alegre, Porto Alegre – RS – Brasil
  • Richard Yudi Hida, Universidade Federal de São Paulo, São Paulo – SP - Brasil
  • Rodrigo Pessoa Cavalcanti Lira, Universidade Estadual de Campinas, Campinas - SP - Brasil
  • Tammy Hentona Osaki, Universidade Federal de São Paulo, São Paulo – SP – Brasil
  • Tiago E. Faria e Arantes, Hospital de Olhos Sadalla Amin Ghanem, Joinville, SC –  Brasil
  • Tiago Prata, Universidade Federal de São Paulo, São Paulo – SP - Brasil
 

 

National advisory editorial board

 
  • Adriana S. Forseto – Hospital Oftalmológico de Sorocaba, Sorocaba – SP - Brasil
  • Ana Luisa Höfling-Lima - Universidade Federal de São Paulo, São Paulo - SP - Brasil
  • André Augusto Homsi Jorge - Universidade de São Paulo, Ribeirão Preto - SP - Brasil
  • Augusto Paranhos Jr - Universidade Federal de São Paulo, São Paulo - SP - Brasil
  • Ayrton Roberto B. Ramos - Hospital Governador Celso Ramos, Florianópolis, SC - Brasil
  • Breno Barth - Universidade Potiguar, Natal, RN – Brasil
  • Bruno Machado Fontes – Centro de Microcirurgia e Diagnóstico – Rio de Janeiro – RJ - Brasil
  • Carlos Eduardo Leite Arieta – Universidade Estadual de Campinas, Campinas – SP - Brasil
  • Cristina Muccioli - Universidade Federal de São Paulo, São Paulo - SP - Brasil
  • Denise de Freitas - Universidade Federal de São Paulo, São Paulo - SP - Brasil
  • Diane Ruschel Marinho - Universidade Federal do Rio Grande do Sul, Porto Alegre – RS - Brasil
  • Eduardo Cunha de Souza - Universidade de São Paulo, São Paulo - SP - Brasil
  • Eduardo Sone Soriano - Universidade Federal de São Paulo, São Paulo - SP- Brasil
  • Elisabeth B. Guimarães – Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo – SP - Brasil
  • Enyr S. Arcieri – Universidade Federal de Uberlândia, Uberlândia – MG - Brasil
  • Érika Hoyama - Hospital de Olhos de Londrina, Londrina, PR - Brasil
  • Fábio Ejzenbaum - Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo - SP - Brazil
  • Flávio Jaime da Rocha - Universidade Federal de Uberlândia, Uberlândia - MG – Brasil
  • Flávio R. L. Paranhos – Universidade Federal de Goiás, Goiânia – GO - Brasil
  • Frederico Castelo Moura – Universidade de São Paulo, São Paulo, SP - Brasil
  • Galton Carvalho Vasconcelos – Universidade Federal de Minas Gerais, Belo Horizonte – MG – Brasil
  • Haroldo Vieira de Moraes Jr – Universidade Federal do Rio de Janeiro, Rio de Janeiro – RJ – Brasil
  • Ivan Maynart Tavares – Universidade Federal de São Paulo, São Paulo – SP - Brasil
  • João Borges Fortes Filho - Universidade Federal do Rio Grande do Sul, Porto Alegre - RS - Brasil
  • João J. Nassaralla Jr - Universidade de Brasília, Brasília - DF – Brasil
  • João Luiz Lobo Ferreira - Hospital Governador Celso Ramos, Florianópolis, SC – Brasil
  • José Álvaro Pereira Gomes – Universidade Federal de São Paulo, São Paulo – SP - Brasil
  • José Beniz Neto - Universidade Federal de Góias, Goiânia - GO - Brasil
  • José Paulo Cabral Vasconcellos - Universidade Estadual de Campinas, Campinas - SP - Brasil
  • Keila Monteiro de Carvalho - Universidade Estadual de Campinas, Campinas - SP - Brasil
  • Lisandro Massanori Sakata - Universidade Federal do Paraná, Curitiba - PR – Brasil
  • Luiz Alberto S. Melo Jr, Universidade Federal de São Paulo, São Paulo – SP - Brasil
  • Luiz V. Rizzo - Universidade de São Paulo, São Paulo - SP – Brasil
  • Marcelo Francisco Gaal Vadas - Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo - SP - Brazil
  • Marcelo Hatanaka - Universidade de São Paulo, São Paulo - SP - Brasil
  • Marcelo Vieira Netto - Universidade de São Paulo, São Paulo - SP - Brasil
  • Maria Cristina Nishiwaki-Dantas - Universidade Federal de São Paulo, São Paulo - SP - Brazil
  • Maria de Lourdes V. Rodrigues - Universidade de São Paulo, Ribeirão Preto - SP – Brasil
  • Martha Maria Motono Chojniak - Hospital A.C. Camargo, São Paulo - SP - Brasil
  • Mathias Mélega – Universidade Estadual de Campinas, Campinas – SP - Brasil
  • Maurício A. Nascimento – Universidade Estadual de Campinas, Campinas – SP - Brasil
  • Maurício Maia - Universidade Federal de São Paulo, São Paulo - SP - Brasil
  • Mauro Campos - Universidade Federal de São Paulo, São Paulo - SP - Brasil
  • Midori Hentona Osaki - Universidade Federal de São Paulo, São Paulo, SP - Brasil
  • Milton Ruiz Alves - Universidade de São Paulo, São Paulo - SP - Brasil
  • Mirko Babic –Universidade de São Paulo, São Paulo – SP - Brasil
  • Mônica Fialho Cronemberger - Universidade Federal de São Paulo, São Paulo - SP – Brasil
  • Norma Allemann – Universidade Federal de São Paulo, São Paulo – SP - Brasil
  • Norma Helen Medina - Secretaria do Estado da Saúde de São Paulo, São Paulo - SP - Brasil
  • Paulo E. Correa Dantas - Universidade Federal de São Paulo, São Paulo - SP - Brazil
  • Priscilla A. Jorge – Universidade de São Paulo, São Paulo – SP - Brasil
  • Ramon Ghanem  - Hospital de Olhos Sadalla Amin Ghanem, Joinville - SC - Brasil
  • Remo Susanna Jr - Universidade de São Paulo, São Paulo - SP - Brasil
  • Roberto Freda – Hospital Banco de Olhos de Porto Alegre, Porto Alegre – RS - Brasil
  • Roberto L. Marback - Universidade Federal da Bahia, Salvador - BA - Brasil
  • Roberto Pinto Coelho - Universidade de São Paulo, Ribeirão Preto - SP - Brasil
  • Rosane da Cruz Ferreira - Universidade Federal do Rio Grande do Sul, Porto Alegre - RS - Brasil
  • Rubens Belfort Jr - Universidade Federal de São Paulo, São Paulo - SP - Brasil
  • Sebastião Cronemberger - Universidade Federal de Minas Gerais, Belo Horizonte - MG - Brasil
  • Sérgio Kwitko - Universidade Federal do Rio Grande do Sul, Porto Alegre - RS - Brasil
  • Sidney Júlio de Faria e Souza - Universidade de São Paulo, Ribeirão Preto - SP - Brasil
  • Silvana Artioli Schellini - Universidade Estadual Paulista Júlio de Mesquita Filho, Botucatu - SP – Brasil
  • Suzana Matayoshi – Universidade de São Paulo, São Paulo – SP - Brasil
  • Taís H. Wakamatsu – Universidade Federal de São Paulo, São Paulo – SP - Brasil
  • Vital Paulino Costa - Universidade de São Paulo, São Paulo - SP – Brasil
 

 

International advisory editorial board

 
  • Andrew Lee - Blanton Eye Institute, Houston, TX - USA
  • Arturo E. Grau Diez – Universidad Catolica de Chile – Santiago - Chile
  • Baruch D. Kuppermann - University of California, Irvine, CA - USA
  • Careen Lowder - Cleveland Clinic, Cleveland, OH - USA
  • Daniel Briscoe – Emek Medical Center, Afula – Israel
  • Daniel Weil – Universidad de Buenos Aires, Buenos Aires - Argentina
  • Emilio Dodds - Consultores Oftalmologicos, Buenos Aires - Argentina
  • Florian Gekeler – University of Tübingen, Tübingen - Germany
  • James Augsburger - University of Cincinnati, Cincinnati, OH - USA
  • José Carlos Cunha Vaz - Universidade de Coimbra, Coimbra - Portugal
  • José C. Pastor Jimeno - Universidad de Valladolid, Valladolid, Espanha
  • Karolinne Maia Rocha – Cole Eye Institute, Cleveland, OH - USA
  • Marcelo Teixeira Nicolela - Dalhouse University, Halifax - Canada
  • Maria Amélia Ferreira - Universidade do Porto, Portugal
  • Mario Guillermo Salcedo - México
  • Miguel N. Burnier - McGill University, Quebec, Canadá
  • Pilar Gomez de Liaño - Universidad Complutense de Madrid, Espanha
  • Richard L. Abbott - University of California, San Francisco, CA - USA
  • Van Charles Lansingh – University of Tenessee Health Science Center, Memphis, UN - USA
  • Zélia Maria da Silva Correa – Johns Hopkins University, Baltimore, MD - USA
 

 

Editorial production

 
  • Editorial secretary
    Claudete N. Moral
    Cláudia Moral
  • Technical Editorial
    Edna Terezinha Rother
    Maria Elisa Rangel Braga
 

 


 

Instructions to authors

 

Scope and policy

 

ABO-ARQUIVOS BRASILEIROS DE OFTALMOLOGIA (ABO, ISSN 0004-2749 - printed version and ISSN 1678-2925 - online version) is the official bimonthly publication of the Brazilian Council of Ophthalmology (Conselho Brasileiro de Oftalmologia - CBO). The purpose of the journal is to publish scientific studies in Ophthalmology, Visual Sciences, and Public Health, encouraging research, as well as qualification and updating of the professionals involved in this field.

 

 

Methods

 

Original manuscripts are accepted only in English. Manuscripts are grouped into one of the following categories, based on the methodology used:

Clinical Studies
Descriptive or analytical studies involving humans or evaluating the literature relevant to humans.

Epidemiological Studies
Analytical studies involving results from human populations.

Laboratory Experimental Studies
Descriptive or analytical studies involving animal models or other biological, physical or chemical techniques.

Theoretical Studies
Descriptive studies involving description and theoretical analysis of new hypotheses based on the knowledge available in the literature. Theoretical results must add new information to literature.

 

 

Types of Manuscripts

 

Manuscripts submitted to ABO should fit into one of the following categories according to their format. The maximum number of words, figures, tables and, references for each type of manuscript are in parentheses at the end of the description for each category. The word count of the manuscript includes the text from the beginning of the introduction up to the end of the discussion; therefore, the following items are not included: title page, abstract, references, acknowledgments, tables and figures, including legends.

Editorials

Editorials are contributed by invitation and should be related to topics of current interest, preferentially related to articles published in the same issue of ABO (title, maximum of 1,000 words, 2 figures or tables, and 10 references).

Original Articles

Original articles present complete experiments with results that have never been published before (title, structured abstract, maximum of 3,000 words, 8 figures or tables, and 30 references). The evaluation of the manuscripts will be based on the following priorities:

  1. New and relevant information based on a study that uses appropriate methodology.
  2. Repetition of information available in the literature, not previously confirmed locally, based on a study that uses appropriate methodology.
  3. Repetition of information available in the literature and previously confirmed locally, based on a study that uses appropriate methodology.

* Manuscripts containing speculative conclusions, unsubstantiated by the results or based on a study with inappropriate methodology will not be accepted.

Case Reports and Case Series

Case reports or case series will be considered for publication when describing rare and original findings that have not been internationally confirmed, or when presenting clinical or surgical responses that can contribute to elucidate the pathophysiology of a disease (title, unstructured abstract, maximum of 1,000 words, 4 figures or tables, and 10 references).

Letters to the Editor

Letters to the editor are considered for publication if they contain comments related to manuscripts previously published in ABO or, exceptionally, the results of original studies with insufficient content to be submitted as Original Article. These letters should present new information or new interpretation of existing information. When the content of the letter refers to an article previously published in ABO, such article should be mentioned in the first paragraph of the letter and included in its reference list. In these cases, the letters will be linked to the article, and the authors of the article will have their right of reply guaranteed in the same issue. Congratulation letters will not be published (title, maximum of 700 words, 2 figures or tables, and 5 references).

Review Articles

Review articles follow the editorial line and are also accepted if submitted. Suggestions of topics for review articles should be sent directly to the editor, but manuscripts cannot be sent without an invitation (title, unstructured abstract, maximum of 4,000 words, 8 figures or tables, and 100 references).

 

 

Editorial Process

 

Manuscripts will only be considered for publication if they meet all the journal's requirements. The editorial office will inform the authors if their manuscript fails to meet such requirements. Upon notification, the corresponding author will have 30 days to make the necessary changes in the manuscript. If the deadline is not met, the manuscript will be excluded from the editorial process.

The manuscripts submitted to ABO are initially evaluated by the editors to check for content compliance with the editorial line of the journal. After this assessment, all manuscripts are sent for peer review. The anonymity of reviewers is preserved throughout the whole process. However, the authors of manuscripts do not remain anonymous.

After the initial editorial evaluation, the reviewers' comments can be sent to the authors to guide the changes to be implemented in the text. After implementing the changes suggested by the reviewers, the revised manuscript should be resubmitted along with a letter (which is sent as a supplementary document) with specific indications of all changes made to the manuscript or the reasons why the suggested changes were not made. Manuscripts that are resubmitted without a letter will be withheld until the editorial office receives the letter. The deadline to submit the new version of the manuscript is 30 days after the authors are informed of the need to make changes in their manuscript. Manuscripts will be excluded from the process if authors fail to meet this deadline. The ultimate publication will be based on the final approval of the editors. Manuscripts submitted to ABO should not be simultaneously considered for publication by other journals. In addition, total or partial publication or translation for publication in another language of the manuscripts submitted to ABO should not be considered without the permission of the editors of ABO.

Authorship
The criteria for authorship of manuscripts in medical journals are well established. Individuals who have contributed in a concrete way during the following three phases of manuscript preparation should be considered authors:

I. Conception and design, acquisition of data, or analysis and interpretation of data.
II. Draft or critical revision of the article for important intellectual content.
III. Final approval of the version to be published.

The authors of manuscripts submitted to ABO should make sure that all authors meet the criteria mentioned above and that all persons who meet these criteria are listed. Individuals who hold headship positions cannot be considered authors of manuscripts based only on their positions. ABO does not accept the participation of honorary authors.

The corresponding author should complete and submit the Author Contribution Statement as a supplementary document.

Guidelines for Excellent Research
It is recommended that authors follow the appropriate guideline bellow before submitting your work:

  • CONSORT (Controlled and randomized clinical trials)
  • STARD (Diagnostic instruments or techniques)
  • PRISMA (Systematic reviews and meta-analyses)
  • STROBE (Observational studies)
 

 

Manuscript Preparation

 

Manuscripts should only be submitted online using the appropriate interface of ABO. The following guidelines were based on the format suggested by the International Committee of Medical Journal Editors (ICMJE) and published in the document: Uniform Requirements for Manuscripts Submitted to Biomedical Journals.

Only the manuscripts complying with these guidelines will be considered for analysis.

The text should be sent as a digital file. Only the following formats are accepted: .doc. The text should be typed double-spaced, in 12 point font. The pages should be numbered in Arabic numerals, starting each section on a new page.

The sections should be presented according to the following sequence: Title page (as a separate document); Abstract and Keywords; Introduction; Methods; Results; Discussion; Acknowledgements (if any); References; Tables (optional) and Figures (optional) including legends.

1. Title Page. It should contain: a) title (no more than 135 characters with spaces); b) authors' names as they should appear in print; c) each author's affiliation* (city, state, country and, if applicable, department, school, university); d) corresponding author's name, address, phone number, and email; e) sources of financial support (if any); f) project number and institution responsible for the approval of the Research Ethics Committee; g) statement of conflicts of interests of all authors; h) clinical trial registration number on a public trials registry.

* Professional or academic degrees, as well as job position will not be published.

Approval of the Institutional Review Board (IRB). All retrospective, cross-sectional, or prospective studies involving primary data collection or clinical and surgical reports should include the project number and name of the institution that provided the approval of the IRB on the title page. Studies involving humans should be compliant with the Declaration of Helsinki, whereas studies involving animals should be in accordance with the principles suggested by the Association for Research in Vision and Ophthalmology (ARVO).

As a supplementary document, the corresponding author should send the IRB approval or its report stating that the evaluation of the project by the Committee is not necessary. The author cannot decide on the need for evaluation by the Research Ethics Committee.

Statement of Conflicts of Interest. The title page should contain the statement of conflicts of interest of all authors (even if there is no conflict of interest). For more information about potential conflicts of interest, refer to: World Association of Medical Editors: Conflict of interest in peer-reviewed medical journals.

All authors should send the Form for Disclosure of Potential Conflicts of Interest as supplementary documents.

Clinical Trials. All Clinical Trials shall include on the title page the registration number in an international registry that allows free access to trial information (examples: U.S. National Institutes of Health, Australian and New Zealand Clinical Trials Registry, International Standard Randomised Controlled Trial Number - ISRCTN, University Hospital Medical Information Network Clinical Trials Registry - UMIN CTR, Nederlands Trial Register, Registros Brasileiros de Ensaios Clínicos).

2. Abstract and Keywords. Structured abstract (Objective, Methods, Results, Conclusions) with no more than 300 words. Unstructured abstract with no more than 150 words. Five keywords in English listed by the National Library of Medicine (MeSH - Medical Subject Headings).

3. Optional Abstract and Keywords in Portuguese. Optional structured abstract (Objective, Methods, Results, Conclusions) with no more than 300 words. Unstructured abstract with no more than 150 words. Five keywords in Portuguese listed by BIREME. Portuguese translation may be provided by ABO at publication.

4. Introduction, Methods, Results, and Discussion. Citations in the text should be numbered sequentially in superscript Arabic numerals and in parentheses. The names of the authors should not be cited in the text.

5. Acknowledgements. This section should include the collaboration of people, groups or institutions that deserve to be acknowledged but do not meet the criteria for authorship. Statisticians and medical editors may meet the criteria for authorship and, in this case, should be acknowledged as authors. When they do not meet the criteria for authorship, they should be mentioned in this section. Writers who are not identified in the manuscript cannot be accepted as authors; therefore, professional writers should be acknowledged in this section.

6. References. Citations (references) of authors in the text should be numbered sequentially in the same order as they are cited and identified using superscript Arabic numerals. References should be in accordance with the format suggested by the International Committee of Medical Journal Editors (ICMJE), based on the examples below.

The titles of the journals should be abbreviated according to the style provided by the List of Journal Indexed in Index Medicus of the National Library of Medicine.

The names of all authors should be cited for references with up to six authors. For studies with seven or more authors, cite only the first six authors followed by et al.

Examples of references:

Journal Articles
Costa VP, Vasconcellos JP, Comegno PEC, José NK. O uso da mitomicina C em cirurgia combinada. Arq Bras Oftalmol. 1999;62(5):577-80.

Books
Bicas HEA. Oftalmologia: fundamentos. São Paulo: Contexto; 1991.

Book Chapters
Gómez de Liaño F, Gómez de Liaño P, Gómez de Liaño R. Exploración del niño estrábico. In: Horta-Barbosa P, editor. Estrabismo. Rio de Janeiro: Cultura Médica; 1997. p. 47-72.

Annals
Höfling-Lima AL, Belfort R Jr. Infecção herpética do recém-nascido. In: IV Congresso Brasileiro de Prevenção da Cegueira; 1980 Jul 28-30, Belo Horizonte, Brasil. Anais. Belo Horizonte; 1980. v.2. p. 205-12.

Dissertations
Schor P. Idealização, desenho, construção e teste de um ceratômetro cirúrgico quantitativo [dissertation]. São Paulo: Universidade Federal de São Paulo; 1997.

Electronic Documents
Monteiro MLR, Scapolan HB. Constrição campimétrica causada por vigabatrin. Arq Bras Oftalmol. [online journal]. 2000 [cited 2005 Jan 31]; 63(5): [about 4 p.]. Available at: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492000000500012&lng=pt&nrm=iso

7. Tables. Tables should be numbered sequentially using Arabic numerals in the order they are mentioned in the text. All tables should have a title and a heading for all columns. Their format should be simple, with no vertical lines or color in the background. All abbreviations (even if previously defined in the text) and statistical tests should be explained below the table. The bibliographical source of the table should also be informed when the table is extracted from another study.

Do not include tables in the main document of the manuscript, they should be uploaded as supplementary documents

8. Figures (graphs, photos, illustrations, charts). Figures should be numbered sequentially using Arabic numerals in the order they are mentioned in the text. ABO will publish the figures in black and white at no cost to the authors. Manuscripts with color figures will be published only whether the color figure is considered necessary, otherwise, it will be published in black and white.

Graphs should be in shades of gray, on a white background and without three-dimensional or depth effects. Instead of using pie charts, the data should be included in tables or described in the text.

Photos and illustrations should have a minimum resolution of 300 DPI for the size of the publication (about 2,500 x 3,300 pixels for a full page). The quality of the images is considered in the evaluation of the manuscript.

The main document should contain all figure legends, typed double-spaced and numbered using Arabic numerals.

Do not include figures in the main document of the manuscript; they should be uploaded as supplementary documents.

9. Abbreviations and Acronyms. Abbreviations and acronyms should be preceded by the spelled-out abbreviation on first mention and in the legends of tables and figures (even if they have been previously mentioned in the text). Titles and abstracts should not contain abbreviations and acronyms.

10. Units of Measurement: Values of physical quantities should be used in accordance with the standards of the International System of Units.

11. Language. Texts should be clear to be considered appropriate for publication in a scientific journal. Use short sentences, written in a direct and active voice. Foreign words should be in italics. Therapeutic agents should be mentioned by their generic names with the following information in parentheses: trade name, manufacturer's name, city, state and country of origin. All instruments or apparatus should be mentioned including their trade name, manufacturer's name, city, state and country of origin. The superscript symbol of trademark ® or ™ should be used in all names of instruments or trade names of drugs. Whenever there are doubts about style, terminology, units of measurement and related issues, refer to the AMA Manual of Style 10th edition.

12. Original Documents. Corresponding authors should keep the original documents and the letter of approval from the Research Ethics Committee for studies involving humans or animals, the consent form signed by all patients involved, the statement of agreement with the full content of the study signed by all authors and the statement of conflict of interest of all authors, as well as the records of the data collected for the study results. 13. Corrections and Retractions. Errors may be noted in published manuscripts that require the publication of a correction. However, some errors pointed out by any reader may invalidate the results or the authorship of a manuscript. If substantial doubt arises about the honesty or integrity of a submitted manuscript, it is the editor's responsibility to exclude the possibility of fraud. In these situations, the editor will inform the institutions involved and the funding agencies about the suspicion and wait for their final decision. If there is confirmation of a fraudulent publication in ABO, the editor will act in compliance with the protocols suggested by the International Committee of Medical Journal Editors (ICMJE) and by the Committee on Publication Ethics (COPE).

Checklist
Before submitting their manuscript, authors should make sure that all the following items are available:

  • Manuscript prepared in accordance with the instructions to authors.
  • Maximum number of words, tables, figures, and references according to the type of manuscript.
  • Title page including the clinical trial registration number is not included in the main document
  • No figures and tables are included in the main document of the manuscript.
  • All figures and tables were uploaded separately as supplementary documents.
  • Author Contribution Statement completed and saved as a digital file to be sent as a supplementary document.
  • Form for Disclosure of Potential Conflicts of Interest of all authors completed and saved as digital files to be sent as supplementary documents.
  • Digital version of the report provided by the Institutional Review Board containing the approval of the project to be sent as a supplementary document.

List of Websites

Princípios de Autoria segundo ICMJE

Formulário de Declaração de Contribuição dos Autores

CONSORT  (Consolidated Standards of Reporting Trials)

STARD (Standards for the Reporting of Diagnostic accuracy studies)

PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)

STROBE (Strengthening the Reporting of Observational studies in Epidemiology)

Interface de envio de artigos do ABO

International Committee of Medical Journal Editors (ICMJE)

Uniform requirements for manuscripts submitted to biomedical journals

Declaração de Helsinque

Princípios da Association for Research in Vision and Ophthalmology (ARVO)

Chamon W, Melo LA Jr, Paranhos A Jr. Declaração de conflito de interesse em apresentações e publicações científicas. Arq Bras Oftalmol. 2010;73(2):107-9.

World Association of Medical Editors: Conflict of interest in peer-reviewed medical journals.

Formulários para Declaração de Conflitos de Interesse

U.S. National Institutes of Health

Australian and New Zealand Clinical Trials Registry

International Standard Randomised Controlled Trial Number - ISRCTN

University Hospital Medical Information Network Clinical Trials Registry - UMIN CTR

Nederlands Trial Register

Registros Brasileiros de Ensaios Clínicos

MeSH - Medical Subject Headings

DeCS - Descritores em Ciências da Saúde

Formatação proposta pela International Committee of Medical Journal Editors (ICMJE)

List of Journal Indexed in Index Medicus

AMA Manual of Style 10th edition

Protocolos da International Committee of Medical Journal Editors (ICMJE)

Protocolos da Committee on Publication Ethics (COPE)

 

 

 


 

Conselho Brasileiro de Oftalmologia Rua Casa do Ator, 1117 - cj.21, 04546-004 São Paulo SP Brazil, Tel: 55 11 - 3266-4000, Fax: 55 11- 3171-0953 - São Paulo - SP - Brazil
E-mail: abo@cbo.com.br